STEM CELL MARKET REPORTS
Claim market intelligence specific for the stem cell sector. Learn profitable opportunities that your company can pursue. Discover trends, metrics, and industry data that separate the top 2% of stem cell companies from the rest of the marketplace.
Because we believe all customers should be repeat customers, all BioInformant products are backed by a progressive 60-Day Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.
To serve of range of industry and government clients, reports can be purchased directly through this site, or alternatively, by fax, telephone, email, or purchase order. Click here for more information on purchasing.
Complete 2013-14 Induced Pluripotent Stem Cell Industry Report (February 2014)
Since the discovery of induced pluripotent stem cells in 2006, a large and thriving research product market has grown into existence. The number of induced pluripotent stem cell products sold worldwide is currently growing at an annual rate of 14.7%. In addition, 22% of all stem cell researchers now self-report having used iPSCs within a research project.
It is clear that iPSCs represent a lucrative product market for research supply companies to pursue, and this report is your guide to claiming maximal profits from the sector.
A distinctive feature of this industry report is a survey of 274 iPSC researchers (131 U.S. / 143 International) that reveals end-user needs, technical preferences, factors influencing purchasing decisions, and more. Claim these insider insights to improve your product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.
And remember, this product has a 100% Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.
Stem Cell Research Products: Opportunities, Tools & Technologies (June 2014)
Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights.
Whether you already supply stem cell research products or you wish to expand your product line, you’ll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition.
This report – published in June 2014 – shows you how to do just that, helping you understand the prevailing market conditions and giving you guidance to strategically position and develop stem cell product lines.
The report also includes an End-User Survey (Scientist Panel) that contains opinions from stem cell researchers worldwide.
Complete 2015-16 Global Cord Blood Banking Industry Report (Pre-Purchase Now)
The cord blood industry has matured substantially, creating both opportunities and serious threats. Threats include accreditation requirements that have increased cost structures, a decline in cord blood transplants, low rates of turn-over for stored cord blood, expensive transplant procedures, and difficulty educating obstetricians about cellular therapy. Other factors that could threaten the industry include: new legislation, changes in transplant reimbursement, the potential for competitive approaches to be shown more optimal, changes in public perception of private vs. public banking, or shifts in government support.
Marketing pressures are also impacting the industry, with the term “cord blood” becoming one of the 20 most expensive search terms on Google ($27.80 per click).
However, there are also emerging opportunities, including the potential to expand market size through increasing public awareness, new clinical trial data supporting applications for cord blood and tissue, improving public perception toward stem cell therapies, and substantial deal-making within the industry.
While these factors vary somewhat by market, there is an advantage to having a global understanding. The report also includes key survey finding from 600+ recent and expectant parents who reveal fears, expectations, and perceptions of cord blood banking. It will guide the decision-making of cord blood banks and investors.
Opportunities in Human Embryonic Stem Cell Products - Trends & Forecasts
to 2017 (October 2013)
Because human embryonic stem cells (hESCs) are the most pluripotent of all stem cells, they have been proposed for use in a range of applications, including toxicology testing, tissue engineering, cellular therapies, and more.
However, hESC research is heavily encumbered by patents held by the University of Wisconsin's Alumni Research Foundation (WARF), which creates significant challenges for companies seeking to develop new products. This 158-page market intelligence report provides guidance for navigating the complex IP landscape and gives you a wealth of valuable market data to ensure you effectively develop hESC products and technologies.
A distinctive feature of this report is a survey of 247 hESC researchers (101 U.S. / 146 International) that reveal research needs, technical preferences, and factors influencing purchasing decisions. This report too comes with a 60-day, no questions asked, money-back guarantee.
Strategic Development of Neural Stem & Progenitor Cell Products (November 2013)
With the possibility of treating and curing chronic neurological diseases such as Parkinson’s and Alzheimer's, the interest in neuronal stem and progenitor cells has become profound in the research community. This means huge opportunities for your stem cell product company.
This market intelligence report gives you detailed guidance to strategically develop and position neural stem cell (NSC) products.
Claim the report to understand advances in NSC research, explore the competitive environment for NSC product development, examine
5-year market growth projections, view trends in NSC grants, patents, and publications, and much more.
With a 60-day money-back guarantee and the opportunity to understand and profit from the NSC product and technology market, we think you should read more.
Mesenchymal Stem Cells, Advances & Applications (June 2013)
Put simply, this report will help you understand and profit from the Mesenchymal stem cell (MSC) market – the fastest growing area of stem cell research.
Updated to reflect the most current trends and including a five year market projection, this report focuses on the advances in MSC research. In 126 pages you’ll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis.
If you’re looking to supply stem cell products to this rapidly growing and well-funded market, then this is the report for you. And, buy today to get our 60-day money-back guarantee.
Survey: 7 Things You Need to Know to Profit from Feeder-Free Culture
In this revealing 2014 survey, 117 human embryonic stem cell (hESC) and human induced pluripotent stem cell (hiPSC) researchers were surveyed to reveal insights into how and why they make decisions when purchasing stem cell culture products. Specifically explored was why researchers elect to use feeder-dependent versus feeder-free culture. Serve the needs of your clients, or your competitors will.
BioInformant also produces custom research for stem cell companies. We enjoy working with companies of different sizes and will work within your budget and timeline, guaranteeing that you will receive market insights that will lead to strategic dominance.
For custom projects, we structure them as a defined project scope and fee. First, we discuss your needs. Next, we offer you 3 Tier Levels to choose from that vary in scope and price. Finally, you choose what combination best meets your needs.
To learn more, please inquire via live chat or call us at 703.859.7617.
(Phone) 703-859-7617 firstname.lastname@example.org (Fax) 614-352-2369
Copyright © 2014 BioInformant Worldwide, L.L.C. All rights reserved.